Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation

This publication has 34 references indexed in Scilit:

• Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis.
  Scandinavian Journal of Gastroenterology, 2002
• Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of Therapy
  Hepatology, 2001
• Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
  Gastroenterology, 2000
• Nucleoside analogues in the treatment of chronic hepatitis B.
  Journal of Gastroenterology and Hepatology, 2000
• Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States
  New England Journal of Medicine, 1999
• Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
  Hepatology, 1999
• A One-Year Trial of Lamivudine for Chronic Hepatitis B
  New England Journal of Medicine, 1998
• Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
  Hepatology, 1998
• Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
  Hepatology, 1998
• Current therapeutic trends in therapy for chronic viral hepatitis
  Journal of Gastroenterology and Hepatology, 1997